BioNTech Grapples with Falling Demand and Restructuring Post-Pandemic

BioNTech, once celebrated for its COVID-19 vaccines, is facing challenges including falling demand, restructuring, and the departure of its founders, as it shifts focus to ambitious cancer trials.

7 May, 13:03 — 7 May, 13:03

Post Share

Sources

Showing 1 of 1 sources

DWHigh112d ago

COVID pioneer BioNTech: The fall of Germany's pandemic hero

BioNTech, once celebrated for its COVID-19 vaccines, is grappling with falling demand, restructuring and the departure of its founders. Can its ambitious cancer trials turn it from a one-hit wonder into a biotech giant?

Read full article →

PERSPECTA

PERSPECTA

BioNTech Grapples with Falling Demand and Restructuring Post-Pandemic

Sources

COVID pioneer BioNTech: The fall of Germany's pandemic hero

Related Stories

Major Cyberattack Compromises Personal Data of 8.7 Million UK Airport Travelers

Meta’s $18 Billion US Settlement Sparks EU Demands for Stricter Child Safety Rules

Analysts Forecast Bitcoin Could Reach $300,000 by 2029

Nvidia’s Unprecedented 2028 Guidance Sparks Broad Market Rally

PERSPECTA